Skip to main navigation

View Corporate site

News & Events
Stock Information
Governance
Financials
Investor Resources

Select Page

Quarterly Results

Show all

2024

Q3

OptimizeRx Reports Third Quarter 2024 Financial Results
OPRX 3rd Quarter 2024 Earnings Conference Call
Form 10-Q

Q2

OptimizeRx Reports Second Quarter 2024 Financial Results
OPRX 2nd Quarter 2024 Earnings Conference Call
Form 10-Q

Q1

OptimizeRx Reports First Quarter 2024 Financial Results
OPRX 1st Quarter 2024 Earnings Conference Call
Form 10-Q

2023

Q4

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
OPRX 4th Quarter 2023 Earnings Conference Call
Form 10-K

Q3

OptimizeRx Reports Third Quarter 2023 Financial Results
OPRX 3rd Quarter 2023 Earnings Conference Call
Form 10-Q

Q2

OptimizeRx Reports Second Quarter 2023 Financial Results
OPRX 2nd Quarter 2023 Earnings Conference Call
Form 10-Q

Q1

OptimizeRx Reports First Quarter 2023 Financial Results
OPRX 1st Quarter 2023 Earnings Conference Call
Form 10-Q

2022

Q4

OptimizeRx Reports Fourth Quarter and Full Year 2022 Financial Results
OPRX 4th Quarter 2022 Earnings Conference Call
Form 10-K

Q3

OptimizeRx Reports Third Quarter 2022 Financial Results
OPRX 3rd Quarter 2022 Earnings Conference Call
Form 10-Q

Q2

UPDATE – OptimizeRx Reports Second Quarter 2022 Financial Results, Innovative Platform Expansions Now Extends Reach to HCPs Across Social Media and Patients at Point-of-Dispense
OPRX 2nd Quarter 2022 Earnings Conference Call
Form 10-Q

Q1

OptimizeRx Reports First Quarter 2022 Financial Results, Revenue Up 22%, Successfully Completes EvinceMed Acquisition
OPRX 1st Quarter 2022 Earnings Conference Call
Form 10-Q

2021

Q4

OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
OPRX 4th Quarter 2021 Earnings Conference Call
Form 10-K

Q3

OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth
OPRX 3rd Quarter 2021 Earnings Conference Call
Form 10-Q

Q2

OptimizeRx Reports Second Quarter 2021 Financial Results, Revenue Up 55% as Leading Pharma Brands Aggressively Seek Improved ROI Through Technology Adoption
OPRX 2nd Quarter 2021 Earnings Conference Call
Form 10-Q

Q1

OptimizeRx Reports First Quarter 2021 Financial Results, Revenue Up 48% on Rising Enterprise Adoption of Digital Health
OPRX 1st Quarter 2021 Earnings Conference Call
Form 10-Q
OPRX 1st Quarter 2021 Earnings Conference Call Transcript 284 KB

2020

Q4

OptimizeRx Reports Q4 2020 Revenue Up 123% to Record $16.4 Million, Driving Net Income of $1.4 Million or $0.08 Per Share
OPRX 4th Quarter 2020 Earnings Conference Call
Form 10-K
OPRX 4th Quarter 2020 Earnings Conference Call Transcript 297.3 KB

Q3

OptimizeRx Third Quarter 2020 Revenue Up 110% to Record $10.5 Million, Driving Non-GAAP Net Income of $1.1 million or $0.07 Per Share
OPRX 3rd Quarter 2020 Earnings Conference Call
Form 10-Q
OPRX 3rd Quarter 2020 Earnings Conference Call Transcript 360.5 KB

Q2

OptimizeRx Reports Second Quarter 2020 Revenue Up 25% to a Record $8.8 Million; First Half Revenue up 34% to Record $16.4 Million, with Accelerated Growth Expected in Second Half
OPRX 2nd Quarter 2020 Earnings Conference Call
Form 10-Q
OPRX 2nd Quarter 2020 Earnings Conference Call Transcript 298.5 KB

Q1

OptimizeRx Reports First Quarter 2020 Results; Revenue Up 46% to a Record $7.6 Million
OPRX 1st Quarter 2020 Earnings Conference Call
Form 10-Q
OPRX 1st Quarter 2020 Earnings Conference Call Transcript 298.1 KB

2019

Q4

OptimizeRx Reports Fourth Quarter and Full Year 2019 Results; Full Year Revenue up 16% to a Record $24.6 Million
OPRX 4th Quarter 2019 Earnings Conference Call
Form 10-K
OPRX 4th Quarter 2019 Earnings Conference Call Transcript 366.5 KB

Q3

OptimizeRx Reports Third Quarter 2019 Results
OPRX 3rd Quarter 2019 Earnings Conference Call
Form 10-Q
OPRX 3rd Quarter 2019 Earnings Conference Call Transcript 301.3 KB

Q2

OptimizeRx Reports Record Second Quarter 2019 Results; Total Revenue Up 37% to $7.0 Million, Net Income up 45% to $407,000 or $0.03 per Diluted Share
OPRX 2nd Quarter 2019 Earnings Conference Call
Form 10-Q
OPRX 2nd Quarter 2019 Earnings Conference Call Transcript 171.7 KB

Q1

OptimizeRx Reports First Quarter 2019 Results; Total Revenue Up 27% to $5.2 Million, Driving Non-GAAP Net Income up 130% to $833,000 or $0.06 per Diluted Share
OPRX 1st Quarter 2019 Earnings Conference Call
Form 10-Q
OPRX 1st Quarter 2019 Earnings Conference Call Transcript 250.3 KB

2018

Q4

OptimizeRx Reports Fourth Quarter 2018 Results; Net Revenue Up 64% to a Record $6.6 Million, Driving First Profitable Year
OPRX 4th Quarter 2018 Earnings Conference Call
Form 10-K
OPRX 4th Quarter 2018 Earnings Conference Call Transcript 268.1 KB

Q3

OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPS
OPRX 3rd Quarter 2018 Earnings Conference Call
Form 10-Q
OPRX 3rd Quarter 2018 Earnings Conference Call Transcript 602.5 KB

Q2

OptimizeRx Reports Second Quarter 2018 Results; Net Revenue Up 78% to Record $5.1 Million, Driving $0.02 EPS
OPRX 2nd Quarter 2018 Earnings Conference Call
Form 10-Q
OPRX 2nd Quarter 2018 Earnings Conference Call Transcript 510 KB

Q1

OptimizeRx Reports First Quarter 2018 Results; Q1 Net Revenue Up 91% to Record $4.1 Million
OPRX 1st Quarter 2018 Earnings Conference Call
Form 10-Q
OPRX 1st Quarter 2018 Earnings Conference Call Transcript 444.5 KB

2017

Q4

OptimizeRx Reports Fourth Quarter and Full Year 2017 Results; Q4 Net Revenue Up 75% to Record $4.0 Million
OPRX 4th Quarter 2017 Earnings Conference Call
OPRX Q4 2017 Conference Call Audio Replay 12.4 MB
Form 10-K
OPRX 4th Quarter 2017 Earnings Conference Call Transcript 256.5 KB

Q3

OptimizeRx Reports Third Quarter 2017 Results; Net Revenue Up 74% to Record $3.1 Million
OPRX 3rd Quarter 2017 Earnings Conference Call
Form 10-Q
OPRX 3rd Quarter 2017 Earnings Conference Call Transcript 604.5 KB

Q2

OptimizeRx Reports Second Quarter 2017 Results; Net Revenue Up 50% to a Record $2.9 Million
OPRX 2nd Quarter 2017 Earnings Conference Call
Form 10-Q

Q1

OptimizeRx Reports First Quarter 2017 Results
Form 10-Q

2016

Q4

OPRX 4th Quarter 2016 Earnings Conference Call
OptimizeRx Corporation Reports Record Fourth Quarter and Full Year 2016 Results
Form 10-K

Q3

OptimizeRx Corporation Reports Third Quarter 2016 Results
Form 10-Q

Q2

OptimizeRx Corporation Reports Second Quarter 2016 Results
Form 10-Q

Q1

OptimizeRx Corporation Reports First Quarter 2016 Results
Form 10-Q

About OptimizeRx Corporation

News & Events
Stock Information
Governance
Financials
Investor Resources

Email Alerts
Investor Contact
RSS Feeds
Print
Twitter
LinkedIn

Privacy Policy

Copyright © 2020 OptimizeRx Corporation. All rights reserved.